Our main objective was to investigate whether OPRM1 was differentially methylated in ME/CFS/FM patients and whether these changes were associated with clinical and neurophysiological measures. This evidence concerns the gene OPRM1 and myalgic encephalomeyelitis/chronic fatigue syndrome.